Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation …
J BladÉ, D Samson, D Reece… - British journal of …, 1998 - pubmed.ncbi.nlm.nih.gov
Criteria for evaluating disease response and progression in patients with multiple myeloma treated
by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the
EBMT. European Group for Blood and Marrow Transplant Criteria for evaluating disease response
and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic
stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and
Marrow Transplant Br J Haematol. 1998 Sep;102(5):1115-23. doi …
by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the
EBMT. European Group for Blood and Marrow Transplant Criteria for evaluating disease response
and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic
stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and
Marrow Transplant Br J Haematol. 1998 Sep;102(5):1115-23. doi …
